GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Herantis Pharma PLC (OHEL:HRTIS) » Definitions » Total Equity

Herantis Pharma (OHEL:HRTIS) Total Equity : €-0.24 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Herantis Pharma Total Equity?

Herantis Pharma's total equity for the quarter that ended in Dec. 2024 was €-0.24 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Herantis Pharma Total Equity Historical Data

The historical data trend for Herantis Pharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Herantis Pharma Total Equity Chart

Herantis Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.59 0.55 -0.06 4.73 -0.24

Herantis Pharma Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -1.86 4.73 2.04 -0.24

Herantis Pharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Herantis Pharma's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=2.571-2.814
=-0.24

Herantis Pharma's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=2.571-2.814
=-0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Herantis Pharma Total Equity Related Terms

Thank you for viewing the detailed overview of Herantis Pharma's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Herantis Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Herantis Pharma PLC (OHEL:HRTIS) » Definitions » Total Equity
Comparable Companies
OHEL:BIOBV OHEL:NANOFH VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT INSM HKSE:02269 BMRN RPRX XKRX:196170 OCSE:GMAB MRNA
Traded in Other Exchanges
N/A
Address
Bertel Jungin Aukio 1, Espoo, FIN, 02600
Website
https://www.herantis.com
Herantis Pharma PLC is a biotech company developing disease-modifying therapies for Parkinson's disease. The company's current development program focuses solely on HER-096, which is a peptidomimetic molecule designed to retain the biological activity of the neuroprotective CDNF protein.

Herantis Pharma Headlines

No Headlines